Literature DB >> 12519321

Long-term outcome after gastrectomy for intractable diabetic gastroparesis.

P J Watkins1, M S Buxton-Thomas, E R Howard.   

Abstract

AIMS: To examine the long-term outlook for patients with intractable vomiting from diabetic gastroparesis who underwent major gastric surgery.
METHODS: Of 18 patients with problems from vomiting referred to the King's Diabetes Centre during the years 1994-2000, seven were considered to suffer irreversible symptoms not alleviated by protracted periods of medical treatment. They were all Type 1 Caucasian diabetic women, mean age 32 years (range 28-37 years) with multiple symptoms of severe autonomic neuropathy. They underwent major gastric surgery comprising 70% gastric resection including pylorus and antrum, with a 60-cm Roux-en-Y loop of jejunum to prevent reflux gastritis.
RESULTS: The vomiting was relieved in six of the seven patients almost immediately after surgery and during review up to more than 6 years post-operatively. There have been no serious relapses, resulting in considerable improvement in quality of life. Unfortunately, three of the patients developed renal failure, two of them needing renal support treatments 2 and 3 years after successful gastrectomy. One patient died suddenly 5 months after successful surgery and one 3 months after starting dialysis.
CONCLUSIONS: Major gastric surgery can, after careful patient selection, effectively relieve distressing vomiting from severe gastroparesis and give a greatly improved quality of life to a small group of seriously disadvantaged patients where risk of subsequent renal failure is high and where life expectancy is poor.

Entities:  

Mesh:

Year:  2003        PMID: 12519321     DOI: 10.1046/j.1464-5491.2003.00872.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  21 in total

1.  Treatment of Gastroparesis.

Authors:  Daniel C. Buckles; Richard W. McCallum
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04

2.  Minimally invasive surgical approach for the treatment of gastroparesis.

Authors:  Joerg Zehetner; Farrokh Ravari; Shahin Ayazi; Afshin Skibba; Ali Darehzereshki; Diana Pelipad; Rodney J Mason; Namir Katkhouda; John C Lipham
Journal:  Surg Endosc       Date:  2012-06-30       Impact factor: 4.584

Review 3.  Gastroparesis--current concepts and considerations.

Authors:  William L Hasler
Journal:  Medscape J Med       Date:  2008-01-23

Review 4.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

Review 6.  Treatment of refractory diabetic gastroparesis: Western medicine and traditional Chinese medicine therapies.

Authors:  Bing Pang; Qiang Zhou; Jun-Ling Li; Lin-Hua Zhao; Xiao-Lin Tong
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis.

Authors:  Joshua P Landreneau; Andrew T Strong; Kevin El-Hayek; Matthew D Kroh; John H Rodriguez
Journal:  Surg Endosc       Date:  2019-07-11       Impact factor: 4.584

8.  Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.

Authors:  Leonel Rodriguez; Rachel Rosen; Michael Manfredi; Samuel Nurko
Journal:  Gastrointest Endosc       Date:  2012-02       Impact factor: 9.427

Review 9.  [Gastroparesis. Definition, diagnostics, and therapy].

Authors:  U von Arnim
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

10.  Clinical guideline: management of gastroparesis.

Authors:  Michael Camilleri; Henry P Parkman; Mehnaz A Shafi; Thomas L Abell; Lauren Gerson
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.